Acute myeloid leukemia in older adults
- 13 July 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 96 (2), 186-193
- https://doi.org/10.1007/s12185-012-1137-3
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutationsLeukemia Research, 2011
- The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcomeLeukemia, 2011
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999Blood, 2010
- FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyBlood, 2010
- Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic SyndromeJournal of Clinical Oncology, 2010
- Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2010
- High-Dose Daunorubicin in Older Patients with Acute Myeloid LeukemiaThe New England Journal of Medicine, 2009
- A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or olderBlood, 2009
- Acute Myeloid Leukemia in the ElderlySeminars in Oncology, 2008
- Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st centuryHaematologica, 2008